Ananda Developments welcomes new investors with 150,000 share subscription [Video]

Ananda Developments Plc (AQSE:ANA) finance director Jeremy Sturgess-Smith talked with Proactive’s Stephen Gunnion about the company’s recent funding and progress. He highlighted the addition of £150,000 after Ananda was approached by new investors, describing it as a strategic top-up to extend its cash runway and potentially support new ventures.

Sturgess-Smith emphasised that all current projects remain fully funded, thanks also to the £2 million raised in September.

He also outlined upcoming regulatory milestones, including submissions to ethics panels for trials and plans to initiate patient recruitment for MRX1, MRX2, and MRX2T therapies in 2025. Sturgess-Smith assured that the new investors, drawn from the company’s trusted network, are committed to its long-term vision.